SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Politics : A US National Health Care System? -- Ignore unavailable to you. Want to Upgrade?


To: i-node who wrote (6431)3/22/2009 7:04:00 PM
From: Lane3  Read Replies (1) | Respond to of 42652
 
You just don't save a lot of money by reimportation of drugs, for example, since the difference in consumer cost ends up being forced into the American drug market.

I reimportantion of drugs is not the question on the table. The question on the table is knee replacements in Costa Rica or Thailand.

You would kind of have to break things down and look at them, as providers, hospitals, and drug companies all have different cost structures.

I disagree. It's pretty simple. If you buy 100 pies near home for $10 each your total cost is $1000. If you buy 80 pies near home at $10 each and 20 pies farther away for $3 each including gas, your total cost is $860. Your pie cost is less.

I think when it comes down to it few Americans would consider LEAVING this country for a significant medical procedure

Perhaps. But that's beside the point. If some people do it, national health care costs are reduced by the amount those people save. It may be a small savings or a large savings depending upon the number of participants but it's still a savings.



To: i-node who wrote (6431)3/24/2009 4:56:29 PM
From: Peter Dierks  Read Replies (1) | Respond to of 42652
 
You just don't save a lot of money by reimportation of drugs, for example, since the difference in consumer cost ends up being forced into the American drug market.

This is obvious to anyone willing to read. Of course it is possible that it would reduce costs in the US in the very short run. The shortages in the intermediate supplying countries will correct the problem. Soon there will be no drugs available for reimportation.



To: i-node who wrote (6431)3/24/2009 5:13:57 PM
From: Joe NYC  Read Replies (2) | Respond to of 42652
 
You just don't save a lot of money by reimportation of drugs, for example, since the difference in consumer cost ends up being forced into the American drug market.

This is the one I don't object to at all. If the drug makers are willing to give discount to, say, Denmark, why not the US?

If Denmark is strongarming the drug makers to lower the price, they will have to realize that they will have to offer it to the US citizens at these prices. If the prices offered by Denmark are too low, let Denmark go without the drug.

Joe